SERAFAST absorbable purple (4/0) HR-17 needle 70 CM box of 24 sutures - Serag & Wiessner (JO153276) - Delynov

What is SERAFAST resorbable violet (4/0)?

SERAFAST from the brand Serag-Wiessner is a monofilament, synthetic, and resorbable surgical suture material. This violet resorbable suture thread is composed of a segmented copolymer combining glycolide and e-caprolactone. It is dyed with violet D+C No 2 dye for optimal visibility during the intervention. This Class III medical device complies with the European Pharmacopoeia monograph for sterile synthetic resorbable monofilament sutures. Its smooth structure allows for atraumatic passage through tissues, making it a relevant choice for practitioners seeking a high-performance 4/0 resorbable thread.

What are the clinical indications for this suture?

This 4/0 suture thread is specifically indicated for soft tissue adaptation or performing ligatures. Its use is recommended when the clinical protocol requires a rapid resorption suture material, with maintenance of tensile strength limited to a period of up to 2 weeks. In oral and implant surgery, it is used for closing flaps or extraction sites where prolonged stability is not required. This product, an Optime equivalent in its resorption category, must be chosen taking into account the healing characteristics specific to each patient, particularly in those with delayed healing.

What are the technical characteristics of the HR-17 needle?

The JO153276 suture is equipped with an HR-17 needle made of high-quality surgical steel. The HR code designates a 1/2 circle round-bodied needle, particularly suitable for deep sutures and ligatures. The number 17 indicates a needle length of 17 mm. This configuration is ideal for 4/0 dental suture, offering precise maneuverability in the restricted spaces of the oral cavity. The associated thread has a length of 70cm, allowing for several stitches or continuous sutures with a single device, while guaranteeing knot security.

What are the contraindications for the use of SERAFAST?

The use of SERAFAST from Serag-Wiessner is strictly contraindicated in situations requiring prolonged or lasting stability of the suture material, such as the fixation of synthetic implants or heart valves. This device must not be used in the central cardiovascular system or the central nervous system. Furthermore, its use is prohibited in patients with a known allergy to any of its components, notably glycolide, e-caprolactone, or violet D+C No 2 dye. It is imperative not to use it if mechanical strength beyond 14 days is necessary for the success of the surgery.

How does resorption occur and what are the precautions?

The resorption of this 4/0 resorbable suture thread occurs by hydrolysis. Its loss of strength is rapid, which limits its tissue support to approximately 2 weeks. This characteristic is advantageous for reducing post-operative discomfort and the need for stitch removal in certain cases. However, the practitioner must exercise caution in patients whose metabolism might slow down healing. Like any foreign body, prolonged contact with saline solutions (urine or bile) can promote the formation of calculi. It is essential to respect appropriate suturing techniques and not to resterilize the product.

Who is the manufacturer and what standards are met?

The device is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Germany. This product bears the CE1014 marking, guaranteeing its compliance with the safety and performance requirements of the European regulations on medical devices. Classified as Class III, SERAFAST meets the strictest standards for surgical implants. Reference JO153276 is delivered in a box of 24 sterile sutures, each 70cm thread being ready for use. The traceability and manufacturing quality of Serag-Wiessner ensure dental surgeons a reliable material for their daily interventions.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.